The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate
about
The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humansLipoprotein(a) as a cardiovascular risk factor: current statusLipoprotein(a), hormone replacement therapy, and risk of future cardiovascular eventsEffect of Nandrolone Decanoate on serum lipoprotein (a) and its isoforms in hemodialysis patientsPCSK9 inhibitors in the prevention of cardiovascular diseaseApolipoprotein[a] secretion from hepatoma cells is regulated in a size-dependent manner by alterations in disulfide bond formationLipoprotein(a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptorThe number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cellsThe Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis.Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biologyEffects of renal replacement therapy on plasma lipoprotein(a) levels.Hormonal influences on lipoprotein(a) metabolism.Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study.Farnesoid X receptor represses hepatic human APOA gene expression.Correlation analysis between serum lipoprotein (a) and the incidence of aortic valve sclerosis.Lipoprotein(a) metabolism: potential sites for therapeutic targets.Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a).Association between high molecular weight apolipoprotein isoforms and lipoprotein levels in advanced chronic kidney disease and the effect of hemodialysis.Preferential influx and decreased fractional loss of lipoprotein(a) in atherosclerotic compared with nonlesioned rabbit aorta.Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans.Sex hormones and lipoprotein(a) concentration.Lipoprotein(a): resurrected by genetics.New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect?Update on lipoprotein(a) as a cardiovascular risk factor and mediator.Lipoprotein(a) as a therapeutic target in cardiovascular disease.Pathobiology of Lp(a) in calcific aortic valve disease.The metabolism of lipoprotein (a): an ever-evolving story.Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis.Future Directions to Establish Lipoprotein(a) as a Treatment for Atherosclerotic Cardiovascular Disease.Structure, function, and genetics of lipoprotein (a).Emerging Therapeutic Options for Lowering of Lipoprotein(a): Implications for Prevention of Cardiovascular Disease.Lipoprotein (a): a historical appraisal.Plasma lipoprotein(a) levels and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5'-flanking region.Expression of a recombinant apolipoprotein(a) in HepG2 cells. Evidence for intracellular assembly of lipoprotein(a).Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9.Dimyristoylphosphotidylcholine induces conformational changes in apoB that lowers lipoprotein(a).Study of apo(a) length polymorphism and lipoprotein(a) concentrations in subjects with single or double apo(a) isoforms.Simultaneous quantitation and size characterization of apolipoprotein(a) by ultra-performance liquid chromatography/mass spectrometry.Adenovirus-mediated apo(a)-antisense-RNA expression efficiently inhibits apo(a) synthesis in vitro and in vivo.Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a].
P2860
Q24562140-F971697B-8229-4546-A4EE-6C12847E8638Q24623225-E8D5D5EC-04A0-4ED3-86A0-EE8C44B6C1E8Q24629580-41CC4FA5-ACB4-41F0-A815-7E34433CEA6CQ24803599-4A2405D2-BE79-4D9F-8BD4-D035CFB793BAQ28071452-368AB4A7-CFE1-4D44-86D7-8B6EAFEC4696Q28206647-DCA0E99D-061B-487A-B4EA-80C0AFB5282CQ28258969-2DCEEC7D-3C1C-4CD6-ACEB-57C6C1992936Q28298392-2312E73A-74B4-4F7C-9152-6F97453682DBQ30234123-A9EE7866-CDCA-4170-AB52-85FCC43DEA2EQ30242031-9B2348E3-E849-44F4-ABD1-372878D5C804Q30437424-08EC1C2A-5333-45F2-95F7-F7206A61A555Q34669332-B598B20E-CF95-4BD4-B548-5FB9F1CE7BD3Q34955900-BFFAED5B-A290-47DF-A3E2-9E27B39F1F5BQ35187047-58DB8065-213C-4285-A5A5-A0E9F6BA4650Q36412236-9DC48F82-3E56-423F-B095-606F85E2C9FCQ36539756-5A5075C6-CF8B-4A01-A0E6-94C177DE8437Q36696683-47C87F49-2965-408A-AB39-ADCA0F78C499Q36752445-DFF7753B-54F4-47F1-8355-1E41222EE824Q37357944-A496A440-B6A1-4EED-B841-332706C38A59Q37603961-52931960-A129-4995-A7BC-CBE62C298375Q37825893-E45C4EB0-36B0-4006-BA44-FF23D50A0595Q38045424-22E6BCB8-534F-4C9E-B49C-E30F9E007E42Q38126418-9EA35C9C-BA6A-4C59-8727-E664D3635948Q38132701-79978586-C1AE-41B5-935B-85D50CEAFFEDQ38213476-444B220C-C5BB-49FE-A625-6C2424FB2BD9Q38620736-67C1C200-BB77-473B-BB94-F9929B099BBBQ38655614-0F54118B-57B4-4782-8F01-F58FE5CF00B5Q38701405-A6DC253A-C4EC-491F-B63D-F575F09CE462Q38727796-0BEDCA37-8126-4A68-84B0-CA55387BB697Q38807488-8A456A5B-39A3-4492-B526-D33C342BDD60Q38985774-68CDE558-0B73-497A-9470-0C1BBA05EC85Q39002143-FEFCA322-FAC7-431E-9D2E-6AE606056427Q39781234-27805106-E88A-497D-8580-67CB73DD6FAAQ41126602-96C6013A-5B41-4F83-A094-7E2B16ABCDFBQ41153491-E72D6EEA-8E63-46F8-94B1-0D657EF59BFFQ42216886-075CB4A5-A358-4CB2-8C17-0C82A34E58BEQ44481616-6EE91653-87C0-4696-93AA-5680DE115E50Q45830031-7E4D12B5-3763-4BF9-A7AE-A5AE7CB99F9DQ45876542-6B381815-D553-416D-83B4-63991D6E057DQ46693462-E524E9F0-33E5-447C-8203-6E467E42996E
P2860
The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
The inverse association of plasma lipoprotein
@nl
The inverse association of pla ...... differences in production rate
@ast
The inverse association of pla ...... differences in production rate
@en
type
label
The inverse association of plasma lipoprotein
@nl
The inverse association of pla ...... differences in production rate
@ast
The inverse association of pla ...... differences in production rate
@en
prefLabel
The inverse association of plasma lipoprotein
@nl
The inverse association of pla ...... differences in production rate
@ast
The inverse association of pla ...... differences in production rate
@en
P2093
P2860
P356
P1476
The inverse association of pla ...... differences in production rate
@en
P2093
Brewer HB Jr
P2860
P304
P356
10.1172/JCI117292
P407
P577
1994-06-01T00:00:00Z